DrugPatentWatch Database Preview
Details for Patent: RE43390
Which drugs does patent RE43390 protect, and when does it expire?
Patent RE43390 protects ALTABAX and is included in one NDA.
This patent has fifty patent family members in thirty-five countries.
This patent has fifty patent family members in thirty-five countries.
Summary for Patent: RE43390
| Title: | Pleuromutilin derivatives as antimicrobials |
| Abstract: | The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy. |
| Inventor(s): | Berry; Valerie Joan (Chester Springs, PA), Dabbs; Steven (Harlow, GB), Frydrych; Colin Henry (Sawbridgeworth, GB), Hunt; Eric (Great Dunmow, GB), Sanderson; Francis Dominic (Harlow, GB), Woodnutt; Gary (Chester Springs, PA) |
| Assignee: | GlaxoSmithKline LLC (Philadelphia, PA) SmithKline Beecham Limited (Brentford, Middlesex, GB) |
| Application Number: | 13/102,156 |
|
Patent Claim Types: see list of patent claims | Compound; Process; Composition; Use; Dosage form; |
Drugs Protected by US Patent RE43390
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aqua Pharms Llc | ALTABAX | retapamulin | OINTMENT;TOPICAL | 022055-001 | Apr 12, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: RE43390
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 9722817 | Oct 29, 1997 |
| United Kingdom | 9813689 | Jun 25, 1998 |
| PCT Information | |||
| PCT Filed | October 27, 1998 | PCT Application Number: | PCT/GB98/03211 |
| PCT Publication Date: | May 06, 1999 | PCT Publication Number: | WO99/21855 |
Non-Orange Book US Patents Family Members for Patent RE43390
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,281,226 | Pleuromutilin derivatives as antimicrobials | ➤ Sign Up |
| RE39128 | Pleuromutilin derivatives as antimicrobials | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent RE43390
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 015987 | ➤ Sign Up | |||
| Austria | 277925 | ➤ Sign Up | |||
| Austria | 525373 | ➤ Sign Up | |||
| Australia | 742167 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
